78793870 - TIME IS BRAIN

Information

• Trademark
• 78793870

• Source

• Serial Number

  78793870

• Registration Number

  3297427

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 18, 2006
  18 years ago

• Registration Date

  September 25, 2007
  17 years ago

• Transaction Date

  June 10, 2014
  10 years ago

• Status Date

  May 02, 2014
  10 years ago

• Published for Opposition Date

  July 10, 2007
  17 years ago

• Location Date

  September 25, 2007
  17 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MUNSON OTT, MARY DEIRD

• Attorney Docket Number

  S-10409

  Attorney Name

  Gary D. Krugman

  Law Office Assigned Location Code

  L40

• Owners

  • PAION DEUTSCHLAND GMBH

Case File Statements

• GS0011: Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use
• GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical preparations, namely, thrombolytic, fibrinolytic anti-coagulative, antithrombotical or neuroprotective substances for the treatment of blood clotting, cell protection and cell regeneration; products from biotechnological methods, namely, proteins fortherapeutic and diagnostic use in the treatment and diagnosis of blood clotting disorders; blood clotting test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use
• GS0101: Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration
• GS0351: Computerized database management, namely, editing, evaluating and processing data for third parties; performance of pre-clinical studies, namely, managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products
• GS0411: Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics
• GS0421: Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; preparation of expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of protein identification, design and development, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of stroke, neuron damage, thrombotic diseases, tumors, cancer, heart diseases including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment

Case File Event Statements

• 5/2/2014 - 10 years ago

  21 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 9/25/2007 - 17 years ago

  20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/10/2007 - 17 years ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/20/2007 - 17 years ago

  18 - NOTICE OF PUBLICATION Type: NPUB

• 5/1/2007 - 17 years ago

  17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 5/1/2007 - 17 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/27/2007 - 17 years ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/27/2007 - 17 years ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/27/2007 - 17 years ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/2/2007 - 17 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 2/2/2007 - 17 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 1/31/2007 - 17 years ago

  10 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 1/31/2007 - 17 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/31/2007 - 17 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 1/5/2007 - 17 years ago

  7 - PAPER RECEIVED Type: MAIL

• 7/10/2006 - 18 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/10/2006 - 18 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/7/2006 - 18 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/22/2006 - 18 years ago

  3 - APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED Type: AMPX

• 3/22/2006 - 18 years ago

  2 - PAPER RECEIVED Type: MAIL

• 1/24/2006 - 18 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP